张盈利,何煜暐

血压变异性体现血压波动情况，血压变异性的增加或减小都有可能促进动脉硬化的进程，近年来，关于异常血压变异性对2型糖尿病周围血管病变的相关机制取得了一些新发现，为了解血压变异性与2型糖尿病性周围血管病变发生的相关关系，本文就血压变异性在2型糖尿病性周围血管病变发生发展中的作用与机制进行综述，旨在为预防2型糖尿病性周围血管病变发生发展提供新的防治策略。

血压变异性；2型糖尿病；2型糖尿病性周围血管病变；研究进展

[1] Towiargi R,Fetyani L,Aljahdali N,Alnofeie A,Alnoamy Y,Ghandorah R,Abduljawad A,Alharbi N,Alghanmi A,AlButi H.Assessment of the Safety,Efficacy,and Benefit of Empagliflozin in Patients With Type 2 Diabetes Mellitus(T2DM)and Heart Failure With Reduced Ejection Fraction(HFrEF)at High Risk for Cardiovascular Events.Cureus.2022 Dec 28;14(12):e33070. [2] Katakami N.Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.J Atheroscler Thromb. 2018 Jan 1;25(1):27-39. [3] 梁涛,刘凤,吴苏源,等.脂蛋白相关磷脂酶A2在2型糖尿病周围血管病变中的临床预测价值[J].临床血液学杂志, 2023,36(06):387-392. [4] Poznyak A,Grechko AV,Poggio P,Myasoedova VA,Alfieri V,Orekhov AN.The Diabetes Mellitus-Atherosclerosis Connection:The Role of Lipid and Glucose Metabolism and Chronic Inflammation.Int J Mol Sci.2020 Mar 6;21(5):1835. [5] Höcht C.Blood pressure variability:prognostic value and therapeutic implications[J].International Scholarly Research Notices,2013,2013(1):398485. [6] 闫春秀,吕聪敏,李小妞,等.原发性高血压患者血压变异性与炎症标志物及颈动脉粥样硬化程度的相关性分析[J].中国循证心血管医学杂志,2022,14(01):102-104+107. [7] Chadachan VM,Ye MT,Tay JC,Subramaniam K,Setia S.Understanding short-term blood-pressure-variability phenotypes:from concept to clinical practice.Int J Gen Med.2018 Jun 22;11:241-254. [8] Wang J,Shen H,Liu J,Xiao C,Chen C,Teng H,Hu J,Yin J.School-based surveillance on visit-to-visit blood pressure variability and high blood pressure in children and adolescents.BMC Cardiovasc Disord.2021 Mar 17;21(1):141. [9] Del Giorno R,Balestra L,Heiniger P S,et al.Blood pressure variability with different measurement methods:Reliability and predictors.A proof of concept cross sectional study in elderly hypertensive hospitalized patients[J].Medicine,2019,98(28):e16347. [10] Parati G,Stergiou GS,Dolan E,Bilo G.Blood pressure variability:clinical relevance and application.J Clin Hypertens(Greenwich).2018 Jul;20(7):1133-1137. [11] Sarafidis PA,Ruilope LM,Loutradis C,Gorostidi M,de la Sierra A,de la Cruz JJ,Vinyoles E,Divisón-Garrote JA,Segura J,Banegas JR. Blood pressure variability increases with advancing chronic kidney disease stage:a cross-sectional analysis of 16 546 hypertensive patients.J Hypertens.2018 May;36(5):1076-1085. [12] Otsuka F,Kramer MC,Woudstra P,Yahagi K,Ladich E,Finn AV,de Winter RJ,Kolodgie FD,Wight TN,Davis HR,Joner M,Virmani R. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries:A pathology study.Atherosclerosis.2015 Aug;241(2):772-82. [13] Furtado R H M,Raz I,Goodrich E L,et al.Efficacy and safety of dapagliflozin in type 2 diabetes according to baseline blood pressure:observations from DECLARE-TIMI 58 trial[J].Circulation,2022,145(21):1581-1591. [14] 赵玉兰,孙明谨.空腹血清生长抑素与2型糖尿病性周围血管病变的相关性研究[J].现代中西医结合杂志,2019,28(20):2240-2243. [15] Song P,Fang Z,Wang H,Cai Y,Rahimi K,Zhu Y,Fowkes FGR,Fowkes FJI,Rudan I.Global and regional prevalence,burden,and risk factors for carotid atherosclerosis:a systematic review,metaanalysis, and modelling study.Lancet Glob Health.2020 May;8(5):e721-e729. [16] Haddad D,Al Madhoun A,Nizam R,et al.Role of Caveolin‐1 in diabetes and its complications[J].Oxidative medicine and cellular longevity,2020,2020(1):9761539. [17] 杨艳,刘丹丹,聂志川.彩色多普勒超声对老年2型糖尿病患者颈动脉病变的诊断价值[J].医学影像学杂志,2023,33(09):1670-1672. [18] Novo S,Carita P,Voi A L,et al.Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up:comparison between the algorithms of the Framingham Heart Study,the European SCORE and the Italian‘Progetto Cuore’[J].Journal of cardiovascular medicine,2019,20(2):91-96. [19] Jeevarethinam A,Venuraju S,Dumo A,et al.Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients:A prospective multicenter study[J].Clinical cardiology,2017,40(9):752-758. [20] 阚艳敏,何文,宁彬,等.颈动脉斑块内钙化分布特征对斑块稳定性的影响[J].中国动脉硬化杂志,2020,28(02):128-133. [21] Gaggini M,Gorini F,Vassalle C.Lipids in Atherosclerosis:Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia.Int J Mol Sci.2022 Dec 21;24(1):75. [22] 许玉冰,何珍翡,魏忠英.彩色多普勒超声对老年2型糖尿病患者下肢血管病变的诊断价值[J].山西医药杂志, 2018,47(15):1772-1773. [23] Nwabuo C C,Yano Y,Moreira H T,et al.Long-term blood pressure variability in young adulthood and coronary artery calcium and carotid intima-media thickness in midlife:the CARDIA study[J].Hypertension,2020,76(2):404-409. [24] Cai C,Wu Y,Yang L,et al.Sodium selenite attenuates balloon injury-induced and monocrotaline-induced vascular remodeling in rats[J]. Frontiers in Pharmacology,2021,12:618493. [25] 杨康妮,李永旺.血压变异性与肾脏血管内皮功能障碍的研究进展[J].新医学,2020,51(11):813-816. [26] Clark D,Nicholls S J,St John J,et al.Visit-to-visit blood pressure variability,coronary atheroma progression,and clinical outcomes[J]. JAMA cardiology,2019,4(5):437-443. [27] Niwa H,Takahashi K,Dannoura M,et al.The association of Cardio-Ankle vascular index and Ankle-brachial index with macroangiopathy in patients with type 2 diabetes mellitus[J].Journal of Atherosclerosis and Thrombosis,2019,26(7):616-623. [28] Liu Z,Zhao Y,Lu F,et al.Day-by-day variability in self-measured blood pressure at home:Effects on carotid artery atherosclerosis, brachial flow-mediated dilation,and endothelin-1 in normotensive and mild–moderate hypertensive individuals[J].Blood pressure monitoring,2013,18(6):316-325. [29] Sugiura T,Takase H,Machii M,et al.Blood pressure variability and the development of hypertensive organ damage in the general population[J].The Journal of Clinical Hypertension,2022,24(11):1405-1414. [30] 武爱萍,马一涵,李兴雨,等.长时血压变异性对动脉硬化的影响研究[J].中国全科医学,2021,24(02):148-153. [31] Lewis J E A,Morris K,Powell T,et al.Combining diabetic foot and retinopathy screening:a step in the right direction?-a feasibility study[J].SAGE open medicine,2020,8:2050312120946244.

点击下载PDF